Forman Medics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 18.02%
- Profit Growth -97.11%
- Ebitda 31.79%
- Net Worth 0.77%
- Total Assets 42.88%
About Forman Medics
Forman Medics Private Limited (FMPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 October 2016 (Eight years and three months 14 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Amitav Sahoo and Sanjukta Sahu serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51909GJ2016PTC094239
-
Company No.
094239
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Oct 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Forman Medics Private Limited offer?
Forman Medics Private Limited offers a wide range of products and services, including Hair Oil, Hair Fall Control Oil, Herbal Soaps, Aloe Vera Soap, Skin Care Cosmetics, Sunscreen Lotion, Body Care Products, Body Lotions, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines.
Who are the key members and board of directors at Forman Medics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amitav Sahoo
|
Director | 28-Oct-2016 | Current |
|
Sanjukta Sahu
|
Director | 28-Oct-2016 | Current |
Financial Performance of Forman Medics.
Forman Medics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.02% increase. The company also saw a substantial fall in profitability, with a 97.11% decrease in profit. The company's net worth moved up by a moderate rise of 0.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Forman Medics?
In 2023, Forman Medics had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Simmo Meditech Private LimitedAmitav Sahoo is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Forman Medics?
Forman Medics has a workforce of 16 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Forman Medics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Forman Medics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.